Literature DB >> 23109452

Health-related quality of life in Egyptian patients after liver transplantation.

Mahasen Mabrouk1, Gamal Esmat, Ayman Yosry, Magdy El-Serafy, Wahid Doss, Naglaa Zayed, Medhat El-Sahhar, Sally Awny, Ashraf Omar.   

Abstract

UNLABELLED: INTRODUCTION-AIM: Health-Related Quality of Life (HRQOL) has become an important focus of patient care and clinical outcomes research with the improvement in patient and graft survival after liver transplantation (LT). The current study was designed to evaluate the post-transplant HRQOL profiles using the Liver Disease Quality of Life 1.0 (LDQOL 1.0) Questionnaire and demonstrate the possible effect of peri-transplant clinical covariates on these profiles.
MATERIAL AND METHODS: Participants included pre-transplant group (waiting-list patients n = 50) and post-transplant group (mean 5 ± 4 years after deceased or living donor LT n = 103) who were recruited from 3 specialized centers in Egypt. We applied the LDQOL 1.0 questionnaire; a 111-item containing the Short Form-36 version 2.0 (SF-36v2) as a generic component supplemented by 75 disease-specific items. The etiology of cirrhosis, co-morbidities, model for end-stage liver disease (MELD), Child-Pugh class and post-operative complications were analyzed.
RESULTS: All recipients had significant higher HRQOL scores than patients in waiting-list using both questionnaire components. Recipients with pre-LT MELD ≥ 15, Child-Pugh class C, history of hepatocellular carcinoma (HCC) demonstrated low HRQOL scores. Recipients without post-operative surgical complications had a statistically better HRQOL using the disease-specific, but not the SF-36v2 component. On the other hand, both components demonstrated non-significant lower scores in recipients with rejection episodes, cytomegalovirus (CMV) infection and hepatitis C recurrence had compared to those without medical complications.
CONCLUSION: Generally HRQOL improves dramatically after LT as assessed by LDQOL questionnaire. Moreover, combined questionnaires can provide accurate information about the possible impaired HRQOL post-LT due to pre-transplant disease severity and post-operative complications.

Entities:  

Mesh:

Year:  2012        PMID: 23109452

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  6 in total

1.  Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.

Authors:  Christian Benzing; Nicco Krezdorn; Julia Förster; Andreas Hinz; Felix Krenzien; Georgi Atanasov; Moritz Schmelzle; Hans-Michael Hau; Michael Bartels
Journal:  HPB (Oxford)       Date:  2016-04-20       Impact factor: 3.647

2.  Quality of Life and Its Determinants in Liver Transplantation Candidates: A Missed Link in Liver Care Program during the Waiting Time for Liver Transplantation.

Authors:  Kamran Bagheri Lankarani; Behnam Honarvar; Mahsa Akbari; Naghmeh Bozorgnia; Maryam Rabiey Faradonbeh; Morteza Bagherpour; Saman Nikeghbalian; Alireza Shamsaeefar; Seyed Ali Malekhosseini
Journal:  Iran J Med Sci       Date:  2022-05

3.  Mode of allocation and social demographic factors correlate with impaired quality of life after liver transplantation.

Authors:  Nils Heits; Gunnar Meer; Alexander Bernsmeier; Rainer Guenther; Bjoern Malchow; Thomas Kuechler; Thomas Becker; Felix Braun
Journal:  Health Qual Life Outcomes       Date:  2015-09-30       Impact factor: 3.186

4.  Health-related quality of life in pediatric liver transplanted patients compared with a chronic liver disease group.

Authors:  Antonella Gritti; Simone Pisano; Tiziana Salvati; Nicolina Di Cosmo; Raffaele Iorio; Pietro Vajro
Journal:  Ital J Pediatr       Date:  2013-09-11       Impact factor: 2.638

5.  Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.

Authors:  Jonathan G Stine; George J Stukenborg; Jennifer Wang; Alden Adkins; Blake Niccum; Alex Zimmet; Curtis K Argo
Journal:  Ann Hepatol       Date:  2019-09-11       Impact factor: 2.400

6.  The effectiveness of stem cell therapies on health-related quality of life and life expectancy in comparison with conventional supportive medical treatment in patients suffering from end-stage liver disease.

Authors:  Adeeb M AlZoubi; Farah Khalifeh
Journal:  Stem Cell Res Ther       Date:  2013-02-25       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.